Laurent Fischer
InvestorDirector; Chair Science and Technology Committee; Member Compensation Committee at atai Life Sciences Β· Independent Director at AtaiBeckley
San Francisco, California, United States
Find your path to Laurent
231 people in our graph share verified history with Laurent β schools, employers, funds. One of them is your warm intro.
About
Laurent Fischer is CEO and President of Adverum Biotechnologies and sits on the boards of Mirum Pharmaceuticals, Lycia Therapeutics, and Teal. He previously chaired CTI Biopharma, led Tobira Therapeutics as CEO (later acquired by Allergan), and held leadership positions at Jennerex, RXCentric, MedVantx, Dupont Pharmaceuticals, Dupont-Merck, and F. Hoffmann-La Roche. He holds an undergraduate degree from the University of Geneva and a medical degree from the Geneva Medical School in Switzerland.
Invests in
Biotech
Experience
- Shinobi TherapeuticsChairman of the Boardcurrent2025 β present
- AtaiBeckleyIndependent Directorcurrent2024 β present
- Lycia TherapeuticsIndependent Directorcurrent2019 β presentSan Francisco Bay Area
- Mirum PharmaceuticalsBoard Of Directorscurrent2019 β presentSan Mateo, California
- Adverum Biotechnologies, Inc.President and Chief Executive Officer2020 β 2025Redwood City, California, United States
- Teal OmicsChair2023 β 2025Palo Alto, California, United States
- CTI BioPharmaChairman Of The Board2017 β 2023Seattle, Washington, United States
- Senti BiosciencesBoard Member2019 β 2020San Francisco Bay Area
- AllerganLiver Therapeutic Area Head, Senior Vice President2016 β 2020San Francisco Bay Area
- Tobira TherapeuticsChief Executive Officer2010 β 2016South San Francisco
- Tobira TherapeuticsDirector, Executive Chairman, Interim CEO2009 β 2010
- Jennerex BiotherapeuticsChairman and CEO2013 β 2014San Francisco Bay Area
- Jennerex BiotherapeuticsPresident and CEO2012 β 2014San Francisco Bay Area
- AIDS Healthcare FoundationBoard member2001 β 2012Greater Los Angeles Area
- Ocera Therapeutics, Inc.Founder and Chief Executive Officer2005 β 2012San Diego
- TelormedixConsultant2009
- Auxeris TherapeuticsPresident and CEO2003 β 2005
- MedVantxCMO and VP of Corporate Development2001 β 2003
- DuPont PharmaceuticalsSr Vice President, Global Virology Group1997 β 2000
- Hoffmann-La RocheMedical Director1993 β 1997
Skills & more
+12 more
Regulatory AffairsCardiologyClinical ResearchStart-upsVenture CapitalCommercializationFDATechnology TransferLicensingSenior Executive LeadershipImmunologyHealthcareFrom Laurent's professional profile.
Investments
Board seats
Lycia TherapeuticsMirum Pharmaceuticals, Inc.Teal
Per the firm's website.
Colleagues at atai Life Sciences
Frequently asked questions
- Who is Laurent Fischer?
- Laurent Fischer is CEO and President of Adverum Biotechnologies and sits on the boards of Mirum Pharmaceuticals, Lycia Therapeutics, and Teal. He previously chaired CTI Biopharma, led Tobira Therapeutics as CEO (later acquired by Allergan), and held leadership positions at Jennerex, RXCentric, MedVantx, Dupont Pharmaceuticals, Dupont-Merck, and F. Hoffmann-La Roche. He holds an undergraduate degree from the University of Geneva and a medical degree from the Geneva Medical School in Switzerland.
- Where does Laurent Fischer work?
- Laurent Fischer is Director; Chair Science and Technology Committee; Member Compensation Committee at atai Life Sciences.
- What does Laurent Fischer invest in?
- Laurent Fischer invests in Biotech.
- What boards does Laurent Fischer sit on?
- Laurent Fischer holds tracked board seats at Lycia Therapeutics, Mirum Pharmaceuticals, Inc., Teal.
- Where did Laurent Fischer go to school?
- Laurent Fischer studied at University of Geneva (M.D., Medicine).
Same school
Also attended University of Geneva88
+ 82 more
Shared employers
Also worked at Shinobi Therapeutics1
Also worked at Senti Biosciences4
Also worked at Jennerex Biotherapeutics2
Also worked at Hoffmann-La Roche147
+ 141 more








































